Analysts and investors are awaiting details behind UnitedHealth Group’s (NYSE: UNH) 2025 outlook when it reports quarterly results on Thursday
1 year ago
WASHINGTON – The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for
Pfizer (NYSE: PFE) will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon (NYSE: HLN), lowering its stake in
On Tuesday, the U.S. Food and Drug Administration proposed that food companies display nutrition labels on the front of the
Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) are among the defendants in six new lawsuits targeting the sale
SAN FRANCISCO – Philips (NYSE: PHG) CEO Roy Jakobs said he still expects subdued demand in China this year due
On Monday, Johnson & Johnson (NYSE: JNJ) said it would buy neurological drug maker Intra-Cellular Therapies (NASDAQ: ITCI) for $14.6
MADRID – On Monday, Mason Capital, the U.S.-based investment fund, said it had sent a letter to Spain’s stock market
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli
NEW YORK – Healthcare dealmakers gathering in San Francisco for the industry’s premier annual conference this week say they expect
On Monday, GSK (NYSE: GSK), the British drugmaker, said it would pay up to $1.15 billion to buy Boston-based biopharmaceutical
Pfizer’s (NYSE: PFE) experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of
